Specify a stock or a cryptocurrency in the search bar to get a summary
Aspen Pharmacare Holdings Limited
LDZAAspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general, local, and regional anesthetic; low molecular weight heparin; regional and spinal anesthetic; and opioid analegesic under the Diprivan, Emla, Fraxiparine, Marcaine, Ultiva, and Xylocaine brand names. It also offers such as sleeping aid, thyroid hormone, immunosuppressant, iron supplement, analgesic anti-inflammatory, and hormone replacement therapy under the Circadin, Eltroxin, Foxair, Imuran, Maltofer, Mybulen, and Ovestin brand names. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa. Address: Aspen Place, Durban, South Africa
Analytics
WallStreet Target Price
–P/E ratio
17.3214Dividend Yield
1.88 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures LDZA
Dividend Analytics LDZA
Dividend growth over 5 years
9 %Continuous growth
2 yearsPayout Ratio 5 years average
10 %Dividend History LDZA
Stock Valuation LDZA
Financials LDZA
Results | 2019 | Dynamics |